MAOIs vs placeboReduction of of anxiety symptoms ‐ Clinician‐rated: LSAS total score · adults with SAnD1 finding from 1 reviewPharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 218 participantsVery low
MAOIs vs placeboReduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD1 finding from 1 reviewPharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 51 participantsVery low
MAOIs vs placeboReduction of of anxiety symptoms ‐ Clinician‐rated: LSAS fear subscale · adults with SAnD1 finding from 1 reviewPharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 51 participantsVery low